dr. olson co-founded multiple biotechnology companies to translate basic discoveries into new therapeutics for muscle disease. he was co-founder of myogen, inc., a biotechnology company focusing on therapies for heart muscle disease. in 2007, he co-founded miragen therapeutics, which is developing new therapeutics for cardiovascular disease, based on micrornas. in 2015, he founded exonics therapeutics, which is working to correct duchenne muscular dystrophy and other muscle diseases by genome editing.